MarketReportsOnline.com adds Global Spinal Cord Stimulation Market Report: 2016 Edition research report of 47 pages on the spinal cord stimulation industry to the pharmaceuticals intelligence collection of its research store.
Pune, Maharastra -- (SBWIRE) -- 06/06/2016 -- Chronic pain is an unpleasant sense of discomfort that persists or progresses over a long period of time. A chronic back pain can be treated through spinal cord stimulation (SCS) therapy. It is a process that uses soft thin wires with electrical leads to be placed in the spinal column through needle so as to cure chronic back pain. This process doesn't eliminate the pain; it just interferes with the signals sent to the brain. The SCS surgery is performed in two stages: trial stimulation and permanent implantation.
Complete report available at http://www.marketreportsonline.com/481194.html
Spinal cord stimulation therapy is used to reduce the pain signals that are sent to the brain through spinal cord which in return release pain relief chemicals. For this process, a spinal cord stimulator also known as dorsal column stimulator, is surgically placed under the skin to send a mild electrical current to the spinal cord. The process has its advantages and disadvantages.
The spinal cord stimulation (SCS) market is vast and remains relatively untouched with huge potential to treat widespread chronic back pain. The global SCS market is expected to increase in the coming years. The US has the chronic back pain prevalence with maximum number of addressable population and system implants.
The key factors driving the growth in the SCS market includes increasing adult population in the US, increasing demand for minimally invasive surgeries, innovation of new technologies & therapies, growing cases of obesity, and rise in ageing demographics. However, there are number of factors which are hindering the growth of the SCS market like high cost associated with therapy, tough regulatory approvals, and major reliance on traditional SCS therapy.
Purchase a copy of this Spinal cord stimulation market research report at USD 800 (Single User License)
The report offers an in-depth analysis of the spinal cord stimulation market segmented into global SCS and regional SCS market, covering the US and outside the US market. Competition in this market is rather concentrated with a few medical device companies dominating the market, through innovation. Medical companies that have been covered in the report include Medtronic Plc., Nevro Corporation, Boston Scientific, and St. Jude Medical.
Few Points from List of charts provided in Spinal Cord Stimulation Market:
Global Spinal Cord Stimulation (SCS) Market by Value (2014-2018E)
Global Spinal Cord Stimulation (SCS) Market by Region (2016E)
Global SCS Addressable Population (2014-2020E)
Global SCS System Implants Volume (2014-2018E)
The US Chronic Back Pain Prevalence (2014-2018E)
The US Addressable SCS Population (2014-2018E)
The US SCS Implant Systems Volume (2014-2018E)
The US SCS Treatment by Indication (2015)
The US SCS Market by Value (2014-2018E)
Addressable SCS Population outside the US (2014-2018E)
SCS Implant Systems Volume outside the US (2014-2018E)
Rechargeable SCS Market outside the US (2015-2020E)
The SCS Market Value outside the US (2014-2018E)
Increasing Adult Population in the US (2015-2020E)
Rising Global Health Care Expenditure (2008-2015E)
Growing Cases of Obesity (2010-2015E)
Worldwide Ageing Population 60 Years or Older (2000-2030E)
Explore more related reports on pharmaceuticals market at
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India